These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline. Smith MZ; Esiri MM; Barnetson L; King E; Nagy Z Dement Geriatr Cogn Disord; 2001; 12(4):281-8. PubMed ID: 11351139 [TBL] [Abstract][Full Text] [Related]
3. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Cummings BJ; Pike CJ; Shankle R; Cotman CW Neurobiol Aging; 1996; 17(6):921-33. PubMed ID: 9363804 [TBL] [Abstract][Full Text] [Related]
4. Pathologic correlates of apraxia in Alzheimer disease. Giannakopoulos P; Duc M; Gold G; Hof PR; Michel JP; Bouras C Arch Neurol; 1998 May; 55(5):689-95. PubMed ID: 9605726 [TBL] [Abstract][Full Text] [Related]
5. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Nagy Z; Esiri MM; Jobst KA; Morris JH; King EM; McDonald B; Litchfield S; Smith A; Barnetson L; Smith AD Dementia; 1995; 6(1):21-31. PubMed ID: 7728216 [TBL] [Abstract][Full Text] [Related]
6. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment. Foveau B; Albrecht S; Bennett DA; Correa JA; LeBlanc AC Acta Neuropathol Commun; 2016 Dec; 4(1):127. PubMed ID: 27931265 [TBL] [Abstract][Full Text] [Related]
7. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. Agarwal P; Holland TM; James BD; Cherian LJ; Aggarwal NT; Leurgans SE; Bennett DA; Schneider JA J Alzheimers Dis; 2022; 88(2):653-661. PubMed ID: 35694918 [TBL] [Abstract][Full Text] [Related]
8. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Williams S; Chalmers K; Wilcock GK; Love S Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825 [TBL] [Abstract][Full Text] [Related]
9. Visual association pathology in preclinical Alzheimer disease. McKee AC; Au R; Cabral HJ; Kowall NW; Seshadri S; Kubilus CA; Drake J; Wolf PA J Neuropathol Exp Neurol; 2006 Jun; 65(6):621-30. PubMed ID: 16783172 [TBL] [Abstract][Full Text] [Related]
11. Activation of caspase-6 in aging and mild cognitive impairment. Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160 [TBL] [Abstract][Full Text] [Related]
12. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Mitchell TW; Mufson EJ; Schneider JA; Cochran EJ; Nissanov J; Han LY; Bienias JL; Lee VM; Trojanowski JQ; Bennett DA; Arnold SE Ann Neurol; 2002 Feb; 51(2):182-9. PubMed ID: 11835374 [TBL] [Abstract][Full Text] [Related]
13. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Giannakopoulos P; Herrmann FR; Bussière T; Bouras C; Kövari E; Perl DP; Morrison JH; Gold G; Hof PR Neurology; 2003 May; 60(9):1495-500. PubMed ID: 12743238 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset. Chen L; Baum L; Ng HK; Chan LY; Pang CP Hum Pathol; 1999 Oct; 30(10):1172-7. PubMed ID: 10534164 [TBL] [Abstract][Full Text] [Related]
15. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Yilmazer-Hanke DM; Hanke J Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378 [TBL] [Abstract][Full Text] [Related]
17. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234 [TBL] [Abstract][Full Text] [Related]
18. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795 [TBL] [Abstract][Full Text] [Related]
19. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996 [TBL] [Abstract][Full Text] [Related]
20. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]